Error: Could not add to watchlist. X

Emmaus Life Sciences Inc

+ Watchlist
EMMA:US
NASDAQ GM
Pending Listing
EMMA:US is pending Listing
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.62
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Emmaus Holdings Inc. is engaged in the discovery, development and commercialization of treatments and therapies for rare diseases. The Company's primary focus is the late-stage development of the amino acid L-glutamine as a prescription drug for the treatment of sickle cell disease ("SCD").
ADDRESS
20725 S. Western Avenue
Suite 136
Torrance, CA 90501
United States
PHONE
1-310-214-0065
Show More